Galileo Research Facts No. 140: Can Galileo Therapy increase muscle force and decrease fall-risk in young obese?
GRFS, Therapy

Galileo Research Facts No. 140: Can Galileo Therapy increase muscle force and decrease fall-risk in young obese?

This study investigated the effects of Galileo Therapy on muscle force and fall-risk in young obese patients (26Hz, pos. 2, 20° squat, 5x60s., 3/week, 6 weeks). The control group performed identical exercises without Galileo. The Galileo group showed significantly higher effects than the control group for example on muscle strength (extensor torque increase by +6%) as well as reduction of fall-risk and fall-rate by -68%...
Continue reading
Galileo Research Facts No. 136: Can Galileo Therapy improve quality of life (QOL) in Fibromyalgia patients?
GRFS, Therapy

Galileo Research Facts No. 136: Can Galileo Therapy improve quality of life (QOL) in Fibromyalgia patients?

This study reported the effects of Galileo Therapy on health related quality of life (HRQOL) in Fibromyalgia patients (12.5Hz, 6x30-60s., 3/week, 12 weeks). Both groups received additional standard therapy, the Galileo group additional Galileo Therapy. While the control groups showed a decrease in health related quality of life (FIQ) by up to 7% the Galileo group showed an improvement with an over-all difference of up to 11%...
Continue reading
Galileo Research Facts No. 126: Can Galileo Therapy improve muscle function and muscle cross-section in Cystic Fibrosis?
GRFS, Therapy

Galileo Research Facts No. 126: Can Galileo Therapy improve muscle function and muscle cross-section in Cystic Fibrosis?

This study investigated the effects of 6 months of Galileo Therapy on muscle function and cross-section in Cystic Fibrosis patients (12Hz, 6min., 5/week (flexibility) + 26Hz 3/week (muscle power)). The Galileo group showed in average an improvement in muscle cross-section (+5,5%), muscle function (jump height +6,1%) as well as movement efficiency (decrease of used muscle force -4,3% but increase in muscle power +4,7%)...
Continue reading
Galileo Research Facts No. 112: Can Galileo Therapy improve muscle power and balance in MS patients?
GRFS, Therapy

Galileo Research Facts No. 112: Can Galileo Therapy improve muscle power and balance in MS patients?

This study investigated safety and the effects of Galileo Therapy on muscle power, balance, flexibility and quality of life in MS (Multiple Sclerosis) patients (15-25Hz, pos. 2.5-4.5, 5-8x1min, 3/week, 8weeks, increasing Intensity). The Galileo group showed significant improvements in Balance (+12,8%), Functional Reach Test (+14.2%), muscle power (Timed up and Go, +10%) and FS-36 Mental Health (+9%)...
Continue reading
Galileo Research Facts No. 80: Can Galileo Therapy increase muscle power in Pulmonary Arterial Hypertension (PAH)?
GRFS, Therapy

Galileo Research Facts No. 80: Can Galileo Therapy increase muscle power in Pulmonary Arterial Hypertension (PAH)?

This study documented the effects of 4 weeks of Galileo Therapy on muscle power and quality of life in patients with Pulmonary Arterial Hypertension (PAH) (20Hz, pos. 2, 60 minutes, 4/week, 4 weeks). The control group received standard physio-therapy the Galileo group additional Galileo Therapy. The Galileo Group showed significantly higher increase in muscle power (+12%) and in quality of life assessment (+23%)...
Continue reading
Galileo Research Facts No. 55: Can Galileo Therapy decrease HbA1c (long-term blood sugar level) and improve balance and power as well?
GRFS, Therapy

Galileo Research Facts No. 55: Can Galileo Therapy decrease HbA1c (long-term blood sugar level) and improve balance and power as well?

This study examined the effects of Galileo Therapy on HbA1c (long-term glucose level), balance and power in 70 to 82 year old (15-30Hz, pos. 3, 3x3 min., 3/week, 6 weeks). The Galileo and Balance Therapy group both received 2/week 60 min. balance, strength and mobility therapy, the Galileo group additional 3/week, 9min. Galileo Therapy. The Galileo group significantly decrease HbA1c and increased balance and power...
Continue reading
Galileo Research Facts No. 54: Can Galileo Training using deep squats effectively reduce fall risk and improve balance in elderly?
GRFS, Home & Wellness

Galileo Research Facts No. 54: Can Galileo Training using deep squats effectively reduce fall risk and improve balance in elderly?

This study reports the effect of 6 months of Galileo Training with and without deep squatting on balance, gait and fall risk in 68 – 79 year old (20Hz, 4 min., 2/week, 6 months). Both groups received Galileo Training, group 1 using static squats at 45° knee angle, group 2 used slow dynamic squats between 45° and 60°. Group 2 improved function in average by 30% more than group 1 with improvements in Balance of 40%...
Continue reading
Galileo Research Facts No. 53: Can 8 weeks of Galileo Therapy at age 80 decrease fall risk and improve quality of life?
GRFS, Therapy

Galileo Research Facts No. 53: Can 8 weeks of Galileo Therapy at age 80 decrease fall risk and improve quality of life?

This study reported the effects of 8 weeks of Galileo Therapy on fall risk, balance and quality of life in high fall risk, frail elderly (age 71 to 88, 15-30Hz, 5*1min., 3/week, 8 weeks). Both groups received additional 180 min. per week training therapy. With only extra 15 minutes per week the Galileo group showed about double the effects of the control group with improvement of quality of life (+44%) and decreased fall risk (-50%)...
Continue reading
Galileo Research Facts No. 42: Can Galileo Therapy improve balance, muscle power and quality of life in elderly?
GRFS, Therapy

Galileo Research Facts No. 42: Can Galileo Therapy improve balance, muscle power and quality of life in elderly?

This study shows the effects of Galileo Therapy on muscle function and quality of life in a nursing home community (2x1 min. 10Hz, 2x1 min. 26Hz, 3/week, 6 weeks). Both groups received additional 3*10 min. per week physiotherapy (gait, balance, strength). The Galileo Therapy group showed significantly higher improvements in all tested aspects than the control group (about +40% on average).
Continue reading